NCT00400738 - The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

HIV Infections

Interventions

DRUG

Saquinavir, lopinavir, ritonavir

arm 1 = LPV/RTV 400/100 mg BID + SQV 1000 mg BID arm 2 = LPV/RTV 400/100 mg BID + SQV 600 mg BID arm 3 = LPV/RTV 266/66 mg BID + SQV 1000 mg BID arm 4 = LPV/RTV 266/66 mg BID + SQV 600 mg BID

Trial Locations (1)

10330

The HIV Netherlands Australia Thailand Research Collaboration, Bangkok